Search Result "HU-211 (DEXANABINOL)"
Nonpsychotropic Synthetic Cannabinoids
Journal: Current Pharmaceutical Design
Volume: 6 Issue: 1 Year: 2000 Page: 1347-1359
Author(s): Emil Pop
Looking Back at Cannabis Research
Journal: Current Pharmaceutical Design
Volume: 6 Issue: 1 Year: 2000 Page: 1313-1322
Author(s): Raphael Mechoulam
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal: Current Drug Targets
Volume: 2 Issue: 3 Year: 2001 Page: 241-271
Author(s): Gene C. Palmer
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2177-2183
Author(s): Anat Biegon
Preface
Journal: Current Pharmaceutical Design
Volume: 6 Issue: 1 Year: 2000 Page: i-i
Author(s): Emil Pop
Editorial [Hot Topic:The Endocannabinoid System in the Brain: From Biology to Therapy (Guest Editor: Mauro Maccarrone)]
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4 Issue: 6 Year: 2005 Page: 613-613
Author(s): Mauro Maccarrone
Will Medicinal Cannabinoids Prove to be Useful Clinically?
Journal: Current Drug Therapy
Volume: 2 Issue: 2 Year: 2007 Page: 143-150
Author(s): Paul F. Smith
Cannabinoid Signaling in Glial Cells in Health and Disease
Journal: Current Neuropharmacology
Volume: 2 Issue: 1 Year: 2004 Page: 115-124
Author(s): Anke Witting, Nephi Stella
[General Articles] Cannabinoids: Mechanisms and Therapeutic Applications in the CNS
Journal: Current Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2003 Page: 2719-2732
Author(s): Alison J. Drysdale, Bettina Platt
Neuroprotective Strategies in Glaucoma
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 14 Year: 2016 Page: 2178-2192
Author(s): Cynthia A. Gossman,John Christie,Mark K. Webster,David M. Linn,Cindy L. Linn